Cheaper anti-cancer drug as effective as expensive drug in treating most common cause of blindness in older adults

Results of a two-year trial, led by Queen's scientist Professor Usha Chakravarthy, and published in The Lancet today (Friday 19 July), show that two drug treatments Lucentis and Avastinare equally effective in treating neovascular or wet age-related macular degeneration (wet AMD)....

Ref : http://www.sciencedirect.com/science/article/pii/S0140673613615019

Cheaper anti-cancer drug as effective as expensive drug in treating most common cause of blindness in older adults